Stock comparison
Mettler-Toledo International
United Therapeutics
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
UTHR
United Therapeutics
Market cap
$24.13B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | MTD | UTHR | Winner |
|---|---|---|---|
| Warren Buffett | 69B | 71B | UTHR |
| Benjamin Graham | 65B | 76B | UTHR |
| Philip Fisher | 63C | 76B | UTHR |
| Peter Lynch | 66B | 62C | MTD |
| Joel Greenblatt | 68B | 46D | MTD |
| Charlie Munger | 74B | 64C | MTD |
| Terry Smith | 70B | 64C | MTD |
Side-by-side metrics
| Metric | MTD | UTHR |
|---|---|---|
| Market cap | $22.29B | $24.13B |
| P/E (TTM) | 25.3x | 19.2x |
| EV/EBIT | 21.6x | 15.2x |
| ROIC (TTM) | 36.09% | 18.81% |
| Gross margin | 57.79% | 86.58% |
| Net margin | 21.4% | 40.61% |
| Revenue CAGR 5y | 2.01% | 17.22% |
| EPS CAGR 5y | 6.12% | 29.84% |
| Debt / Equity | - | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
MTD leads on
- Debt / Equity-vs -+100%
- ROIC (TTM)36.09%vs 18.81%+48%
UTHR leads on
- Revenue CAGR 5y17.22%vs 2.01%+88%
- EPS CAGR 5y29.84%vs 6.12%+79%
- Net margin40.61%vs 21.4%+47%
- Gross margin86.58%vs 57.79%+33%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.